ANNE STUBBS: Open Payments
NPI 1205177003 · VIRGINIA BEACH, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,698 in 77 payments from 13 companies in 2025. Trend: 2023 $1,869 · 2024 $1,662 · 2025 $1,698
Food & beverage: $1,698
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $646 |
| E.R. Squibb & Sons, L.L.C. | 14 | $323 |
| Otsuka America Pharmaceutical, Inc. | 11 | $185 |
| Supernus Pharmaceuticals, Inc. | 7 | $118 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $103 |
| Lundbeck LLC | 5 | $95 |
| Vanda Pharmaceuticals Inc. | 4 | $67 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $58 |
| Neurocrine BioSciences, Inc. | 2 | $35 |
| Janssen Pharmaceuticals, Inc | 1 | $20 |
Products named: VRAYLAR, COBENFY, REXULTI, Qelbree, ABILIFY ASIMTUFII, CAPLYTA, FANAPT, TRINTELLIX.
Industry payments across VA — which companies pay providers there.
